CLVS logo

Clovis Oncology (CLVS) Selling, General & Administrative Expenses

Annual SGA

$128.40 M
-$35.49 M-21.66%

December 31, 2021

Summary

Performance

1-Year Change

-21.66%

3-Year Change

-26.95%

5-Year Change

-7.56%

15-Year Change

-7.56%

CLVS SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$182.77 M
CLVS annual SGA is currently -29.75% below its historical high of $182.77 million

3-Year Low

$128.40 M
CLVS annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CLVS previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CLVS next annual earnings announcement has not yet been scheduled

OtherCLVSexpensesmetrics:

Annual Total Expenses

$369.05 M
CLVS annual total expenses is $369.05 million

Annual Operating Expenses

$330.22 M
CLVS annual total operating expenses is $330.22 million

Annual Cost Of Goods Sold

$38.83 M
CLVS annual cost of goods sold is $38.83 million

Annual Interest Expense

$31.67 M
CLVS annual interest expense is $31.67 million

Quarterly SGA

$30.38 M
-$2.21 M-6.78%

September 30, 2022

Summary

Performance

3-Month Change

-6.78%

1-Year Change

-5.64%

3-Year Change

-27.34%

5-Year Change

-13.23%

CLVS Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$49.15 M
CLVS quarterly SGA is currently -38.19% below its historical high of $49.15 million

3-Year Low

$29.21 M
CLVS quarterly SGA is currently +3.99% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
CLVS previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
CLVS next earnings announcement has not yet been scheduled

OtherCLVSexpensesmetrics:

Quarterly Total Expenses

$74.90 M
CLVS quarterly total expenses is $74.90 million

Quarterly Operating Expenses

$66.29 M
CLVS quarterly total operating expenses is $66.29 million

Quarterly Cost Of Goods Sold

$8.61 M
CLVS quarterly cost of goods sold is $8.61 million

Quarterly Interest Expense

$9.30 M
CLVS quarterly interest expense is $9.30 million

TTM SGA

-$11.89 B
-$251.90 M-2.16%

September 30, 2022

Summary

Performance

3-Month Change

-9435.49%

1-Year Change

-8853.35%

3-Year Change

-6604.49%

5-Year Change

-6604.49%

CLVS TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$54.93 M

3-Year Low

-$11.89 B
CLVS TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2022
CLVS previous earnings announcement was published on Sep 30, 2022

Next Quarterly Earnings Report Date

N/A
CLVS next earnings announcement has not yet been scheduled

OtherCLVSexpensesmetrics:

Annual Total Expenses

$369.05 M
CLVS annual total expenses is $369.05 million

Annual Operating Expenses

$330.22 M
CLVS annual total operating expenses is $330.22 million

TTM Cost Of Goods Sold

$36.97 M
CLVS TTM cost of goods sold is $36.97 million

TTM Interest Expense

$34.91 M
CLVS TTM interest expense is $34.91 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$128.40 M
CLVS annual SGA is $128.40 million

Annual Operating Expenses

$330.22 M
CLVS annual total operating expenses is $330.22 million

Annual Cost Of Goods Sold

$38.83 M
CLVS annual cost of goods sold is $38.83 million

CLVS Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-21.7%-5.6%-8853.4%
3 y3 years-26.9%-27.3%-6604.5%
5 y5 years-7.6%-13.2%-6604.5%

CLVS Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-8.9%-3.8%+7.0%at low
5 y5-year-29.7%at low-32.7%-3.8%+42.1%at low
alltimeall time-29.7%-96.6%-38.2%-97.3%>+9999.0%at low

Clovis Oncology Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2022
-
$30.38 M(-6.8%)
$125.53 M(-1.4%)
Jun 2022
-
$32.59 M(+11.6%)
$127.34 M(-0.3%)
Mar 2022
-
$29.21 M(-12.4%)
$127.67 M(-0.6%)
Dec 2021
$128.40 M(-21.7%)
$33.34 M(+3.6%)
$128.40 M(-5.5%)
Sep 2021
-
$32.20 M(-2.2%)
$135.81 M(-4.5%)
Jun 2021
-
$32.92 M(+9.9%)
$142.25 M(-5.9%)
Mar 2021
-
$29.94 M(-26.5%)
$151.24 M(-7.7%)
Dec 2020
$163.89 M(-10.3%)
$40.76 M(+5.5%)
$163.89 M(-2.6%)
Sep 2020
-
$38.64 M(-7.8%)
$168.30 M(-1.9%)
Jun 2020
-
$41.90 M(-1.6%)
$171.48 M(-3.4%)
Mar 2020
-
$42.60 M(-5.7%)
$177.61 M(-2.8%)
Dec 2019
$182.77 M(+4.0%)
$45.17 M(+8.0%)
$182.77 M(-2.1%)
Sep 2019
-
$41.81 M(-12.9%)
$186.75 M(-0.4%)
Jun 2019
-
$48.03 M(+0.6%)
$187.43 M(+1.7%)
Mar 2019
-
$47.76 M(-2.8%)
$184.27 M(+4.8%)
Dec 2018
$175.78 M(+26.5%)
$49.15 M(+15.7%)
$175.78 M(+6.4%)
Sep 2018
-
$42.49 M(-5.3%)
$165.16 M(+4.7%)
Jun 2018
-
$44.86 M(+14.2%)
$157.67 M(+5.9%)
Mar 2018
-
$39.27 M(+1.9%)
$148.96 M(+7.2%)
Dec 2017
$138.91 M(+241.0%)
$38.52 M(+10.0%)
$138.91 M(+23.4%)
Sep 2017
-
$35.01 M(-3.1%)
$112.57 M(+29.8%)
Jun 2017
-
$36.15 M(+23.7%)
$86.72 M(+44.2%)
Mar 2017
-
$29.22 M(+139.7%)
$60.13 M(+47.6%)
Dec 2016
$40.73 M
$12.19 M(+33.0%)
$40.73 M(+10.7%)
Sep 2016
-
$9.16 M(-4.1%)
$36.78 M(+2.3%)
DateAnnualQuarterlyTTM
Jun 2016
-
$9.55 M(-2.8%)
$35.95 M(+7.0%)
Mar 2016
-
$9.83 M(+19.3%)
$33.60 M(+10.1%)
Dec 2015
$30.52 M(+42.3%)
$8.24 M(-1.1%)
$30.52 M(+9.4%)
Sep 2015
-
$8.33 M(+15.6%)
$27.89 M(+12.3%)
Jun 2015
-
$7.20 M(+6.7%)
$24.83 M(+8.5%)
Mar 2015
-
$6.75 M(+20.4%)
$22.89 M(+6.7%)
Dec 2014
$21.46 M(+29.5%)
$5.61 M(+6.4%)
$21.46 M(+0.3%)
Sep 2014
-
$5.27 M(+0.0%)
$21.40 M(+4.7%)
Jun 2014
-
$5.26 M(-1.0%)
$20.44 M(+9.5%)
Mar 2014
-
$5.32 M(-4.1%)
$18.67 M(+12.7%)
Dec 2013
$16.57 M(+55.7%)
$5.54 M(+28.6%)
$16.57 M(+20.1%)
Sep 2013
-
$4.31 M(+23.5%)
$13.79 M(+12.7%)
Jun 2013
-
$3.49 M(+8.5%)
$12.24 M(+7.1%)
Mar 2013
-
$3.22 M(+16.1%)
$11.43 M(+7.5%)
Dec 2012
$10.64 M(+55.1%)
$2.77 M(+0.3%)
$10.64 M(+7.4%)
Sep 2012
-
$2.76 M(+3.1%)
$9.90 M(+11.8%)
Jun 2012
-
$2.68 M(+10.5%)
$8.86 M(+12.4%)
Mar 2012
-
$2.42 M(+19.1%)
$7.88 M(+14.9%)
Dec 2011
$6.86 M(+59.5%)
$2.04 M(+18.8%)
$6.86 M(+13.2%)
Sep 2011
-
$1.71 M(+0.5%)
$6.06 M(+11.6%)
Jun 2011
-
$1.71 M(+21.4%)
$5.43 M(+11.3%)
Mar 2011
-
$1.41 M(+13.6%)
$4.88 M(+13.4%)
Dec 2010
$4.30 M
$1.24 M(+14.2%)
$4.30 M(+40.4%)
Sep 2010
-
$1.08 M(-6.0%)
$3.06 M(+54.6%)
Jun 2010
-
$1.15 M(+38.8%)
$1.98 M(+138.8%)
Mar 2010
-
$830.00 K
$830.00 K

FAQ

  • What is Clovis Oncology annual SGA?
  • What is the all time high annual SGA for Clovis Oncology?
  • What is Clovis Oncology annual SGA year-on-year change?
  • What is Clovis Oncology quarterly SGA?
  • What is the all time high quarterly SGA for Clovis Oncology?
  • What is Clovis Oncology quarterly SGA year-on-year change?
  • What is Clovis Oncology TTM SGA?
  • What is the all time high TTM SGA for Clovis Oncology?
  • What is Clovis Oncology TTM SGA year-on-year change?

What is Clovis Oncology annual SGA?

The current annual SGA of CLVS is $128.40 M

What is the all time high annual SGA for Clovis Oncology?

Clovis Oncology all-time high annual SGA is $182.77 M

What is Clovis Oncology annual SGA year-on-year change?

Over the past year, CLVS annual SGA has changed by -$35.49 M (-21.66%)

What is Clovis Oncology quarterly SGA?

The current quarterly SGA of CLVS is $30.38 M

What is the all time high quarterly SGA for Clovis Oncology?

Clovis Oncology all-time high quarterly SGA is $49.15 M

What is Clovis Oncology quarterly SGA year-on-year change?

Over the past year, CLVS quarterly SGA has changed by -$1.82 M (-5.64%)

What is Clovis Oncology TTM SGA?

The current TTM SGA of CLVS is -$11.89 B

What is the all time high TTM SGA for Clovis Oncology?

Clovis Oncology all-time high TTM SGA is -$54.93 M

What is Clovis Oncology TTM SGA year-on-year change?

Over the past year, CLVS TTM SGA has changed by -$12.02 B (-8853.35%)